CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Thapa, Bicky, Caimi, Paolo F., Ardeshna, Kirit M., Solh, Melhem, Carlo-Stella, Carmelo, Kahl, Brad S., Hamadani, Mehdi
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2020
Matèries:
Commentary
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7448593/
https://ncbi.nlm.nih.gov/pubmed/32797191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002587
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars